Methods: 1. Specify how many patients were excluded because of missing BMI data. Also, total participants excluded from multivariable analysis because of missing data in included covariates is relevant.
2. For multivariable analysis, since the point is to account for confounding (not prediction), I would include variables known confounders in the BMI to mortality association, using an analytical framework. For instance, I noticed that diabetes was included in the model, which is considered a mediator (rather than confounder) in the BMI mortality association (high BMI cause diabetes, and diabetes cause CVD and death). When mediators are included in the model, the estimates of the BMI-mortality association are affected with bias (overadjustment, usually towards the null, but this is unpredictable). Therefore, I would recommend to remove diabetes, and add smoking status (a well-known confounder, and this analysis also shows that obese patients have less current smoking rates).
3. Also, there is some clustering nature of the data, since data comes from 15 different centers. This can be accounted in the analysis. One way is to do it including center as fixed effects in the model, but the most standard way is to include it as random effect through shared frailty modelling. I understand that shared frailties modelling is not available in SPSS but is available on SAS and STATA.
4. I would suggest to delete the last paragraph of methods and just report how many patients had missing data in BMI and other covariates included in the model. Explanation: I do not agree with the assumption of missing data completely at random. Quantitative methods, like Little"s test for assessing MCAR, are highly criticized, and MCAR rarely happens in practice. Indeed, this can be easily demonstrated by reporting mortality rates of those with missing data on BMI and those with available BMI data, very likely to be highly significant. Usually, patients with missing data (especially weight and height in patients presenting with STEMI) has to do the critical condition of the patient, and therefore not completely at random for the outcome mortality. If missing data in the final covariates included in the final model is under 5%, list-wise deletion or "complete case analysis" is reasonable. If is way over 5%, multiple imputation is recommended as standard practice.
Results: 1. In Outcomes, report the P value of normal BMI vs overweight and obese, only one p-value is reported. 2. Please leave your comments for the authors below Comment 1) Only minor comment on the writing style and language used. There is no need to keep emphasizing the words " our local Malaysian population". Our study population should suffice. The word either 'Race' or 'Ethnicity' should be used. Not both Response: Thank you for pointing this out. We have changed them accordingly, and the term "ethnicity" is used instead of "Race"
Comment 2) Please demonstrate that there are no differences in outcome between the 3 ethnic groups in terms of outcome and the 'Obesity Paradox"
Response:
In view of the other reviewer"s suggestion, we have re-run the statistical analysis, with multiple imputation done to handle the missing data prior to running the multivariable analysis, and addition of smoking status as covariate in the multivariable analysis. Ethnicity was also added in the model, with "Malay" group as the reference group. The latest result showed that Chinese and Indian ethnicities had lower hazard ratios (HR:0.67, CI: 0.52-0.87, p=0.002 and HR:0.71, CI:0.55-0.92, p=0.009 respectively) compared to Malay. We have added this finding briefly into the latest revised text, in the outcome paragraph (page 11). However, our study objective was not to assess the association between ethnicity and outcomes after PCI and therefore it was not emphasized much in the text.
Reviewer: 2 Sanjit Jolly and Pablo Lamelas
The Population Health Research Institute, Canada Please state any competing interests or state "None declared": none declared Please leave your comments for the authors below Dr Azhari and colleagues present a large analysis with 1 year follow-up describing a survival advantage of overweight and obese patients among patients receiving PCI. This analysis has relevant positive strengths including: 1) large size with one year follow-up, 2) study the obesity paradox in underrepresented ethnicities in the literature (compared to western communities, where most obesity paradox data comes from, and BMI accuracy to predict body fat is altered by Asian vs non-Asian), 3) uses ethnic specific cut-off points, which I am not aware was done in prior analyses. Although we think this article adds relevant insights to existing literature, we think that can be improved with the comments below. ABSTRACT 1. Objectives: Use "BMI" instead of obesity Outcome measures: specify "multivariable"
Response:
We have made the amendment as suggested.
2. Conclusions: add a line of implications of research, or the fact that Asian specific cutoff points were used may be added as well.
Response: Thank you for your suggestion. We have added the phrase "Using Asian specific BMI cut-off points," at the beginning of the conclusion.
3. Abstract can be improved by removing redundant information.
Response: Thank you for the suggestion. We have removed some of the redundant phrases in the abstract, mainly from the "Result" section.
TEXT Methods: 1. Specify how many patients were excluded because of missing BMI data. Also, total participants excluded from multivariable analysis because of missing data in included covariates is relevant.
Regarding your first suggestion, we have added the information in the second and third paragraph under the "Study Design" heading in the "Methods" section (Page 7). There were 7268 patients were excluded from analysis due to either missing BMI values or "implausible" BMI values.
Regarding the second suggestion, we did not include it in the main text as we have decided to re-run the multivariable analysis with multiple imputation method to handle the missing data in the covariates to be included in the model. The decision to use multiple imputation was because of your suggestion in the second comment below which was to include smoking in the model, and smoking was previously excluded from our model due to high percentage of missing values. We had added an extra column in our baseline and premorbid characteristics table (Table 1 to Table 3 (page 22 to 24)) that shows the number of missing values for each variable.
2. For multivariable analysis, since the point is to account for confounding (not prediction), I would include variables known confounders in the BMI to mortality association, using an analytical framework. For instance, I noticed that diabetes was included in the model, which is considered a mediator (rather than confounder) in the BMI mortality association (high BMI cause diabetes, and diabetes cause CVD and death). When mediators are included in the model, the estimates of the BMI-mortality association are affected with bias (overadjustment, usually towards the null, but this is unpredictable). Therefore, I would recommend to remove diabetes, and add smoking status (a wellknown confounder, and this analysis also shows that obese patients have less current smoking rates).
Response: Thank you for the detailed explanation and the suggestion. We completely agree with the concept of mediators vs confounders as pointed by you. However, other than diabetes, variables such as hypertension and dyslipidemia have been also postulated to be "mediators" in the association pathway between BMI and cardiovascular outcomes [1] . Removing diabetes from the model due to its mediator property would necessitate the removal of hypertension and dyslipidemia variables as well. Furthermore, our literature reviews of previous studies regarding association between BMI and cardiovascular outcome showed that majority of them included diabetes and hypertension in their multivariable analysis model (some examples are our references no. 15, 16,19 to 23). Therefore we decided to include diabetes, hypertension and dyslipidemia in the final model.
Regarding smoking status, we agree with you that it is a well-known confounder for BMI and cardiovascular outcomes. However, it was not included in our initial model for two reasons: 1) A separate univariate analysis failed to show a significant association between smoking status and 1 year mortality after PCI (p= 0.47) in our study population, and 2) There was a high percentage of missing value for smoking status in our population (12.9%, with 3715 missing values).
To include smoking into the model as suggested by you, we had re-run the analysis by carrying out multiple imputation to the missing values in all the included covariates (except BMI) and repeated the multivariable analysis using the imputed data with smoking included in the final model. By doing so, the overweight group remained to have significantly better outcome than normal BMI group (HR:0.71, p=0.005) but the obese group had loss its significance as a predictor of better outcome (HR:0.78, p=0.056).
We have updated this new result in the abstract and the main text, and a significant portion of the discussion part had been revised to account for this finding (page 3, 11, 13 to 15, 26, 27).
[1] Lu Y et al. Mediators of the effect of body mass index on coronary heart disease: decomposing direct and indirect effects. Epidemiology. 2015; 26:153-62 . doi: 10.1097/EDE.0000000000000234 3. Also, there is some clustering nature of the data, since data comes from 15 different centers. This can be accounted in the analysis. One way is to do it including center as fixed effects in the model, but the most standard way is to include it as random effect through shared frailty modelling. I understand that shared frailties modelling is not available in SPSS but is available on SAS and STATA.
Response: Your comment and suggestion are much appreciated. However, we decided not to include this in the model because the number of participating centers was not constant since 2007 until 2014 (it has increased from eight to fifteen), and each center"s level of expertise also had markedly changed throughout the eight years period. Not accounting for this covariate is a significant limitation to our multicentre registry study, and we have therefore added an extra paragraph explaining this in the "Limitation" section (page 17).
Response: Thank you for your detailed explanation regarding handling of missing data. We have removed the last paragraph regarding MCAR in the "Methods" section . As mentioned earlier, we have added the number of patients with missing BMI data in the final paragraph under the "Study design" heading in the "Methods" section (Page 7), and for the covariates, the number of their missing values had been added into Table 1 to Table 3 (page 22, 23).
Results: 1. In Outcomes, report the P value of normal BMI vs overweight and obese, only one p-value is reported.
Response: Done. Thank you for pointing this to us.
2. Table 1 repeats information with figure 1, remove one please Response: Figure 1 is a visual representation of the hazard ratios presented in Table 7 . We have removed Figure  1 and keep Table 7 . Thank you. 
GENERAL COMMENTS
The manuscript was substantially improved by the authors, they properly addressed all my comments and made a large effort (like re running the results with multiple imputation). I have just a few comments:
1. When I mentioned that diabetes is part of the causal pathway of BMI and mortality, was an example and I also agree that hypertension and hyperlipidemia (I didn"t know that these were included as well). I also think that citing articles that did include "proven or likely" mediators in a model is not evidence that is done properly, and is clearly not appropriate, biasing estimates (I suggest the following article Overadjustment Bias and Unnecessary Adjustment in Epidemiologic Studies Enrique F. Schistermana, Epidemiology. 2009 July ; 20(4): 488-495. doi:10.1097/EDE.0b013e3181a819a1.) . However, I have to admit that doing sensitivity analysis including them or not in prior BMI projects I worked on did not change the estimates significantly, so if want to keep them is ok.
2. Confounder selection and inclusion in causal models should not be based on statistical findings (vs include the significants in prediction models), but should be based on the understanding of the causal framework (Logistic Regression (book), by Kleinbaum, David G., Klein, Mitchel).
The reason why smoking is non-significant for mortality in univariable analysis is related to the "tobacco paradox" that has been shown to be reverted (or proven wrong) with adequate adjustment and repeated measures analysis from the SYNTAX trial, among others. Tobacco is clearly unbalance between normal weights and obese, increase risk of death, therefore should be in the model regardless of univariate analysis.
VERSION 2 -AUTHOR RESPONSE
Reviewer 2 comment 1.When I mentioned that diabetes is part of the causal pathway of BMI and mortality, was an example and I also agree that hypertension and hyperlipidemia (I didn"t know that these were included as well). I also think that citing articles that did include "proven or likely" mediators in a model is not evidence that is done properly, and is clearly not appropriate, biasing estimates (I suggest the following article
Our response:
We appreciate the constructive input from the reviewer regarding this, and the article mentioned also provided a nice explanation about mediators vs confounders and overadjustment. As for our study, we decided to keep diabetes, hypertension and dyslipidemia in the model, and therefore no new changes were made.
2. Confounder selection and inclusion in causal models should not be based on statistical findings (vs include the significants in prediction models), but should be based on the understanding of the causal framework (Logistic Regression (book), by Kleinbaum, David G., Klein, Mitchel). The reason why smoking is non-significant for mortality in univariable analysis is related to the "tobacco paradox" that has been shown to be reverted (or proven wrong) with adequate adjustment and repeated measures analysis from the SYNTAX trial, among others. Tobacco is clearly unbalance between normal weights and obese, increase risk of death, therefore should be in the model regardless of univariate analysis.
Our response: Again, we really appreciate the explanation given by the reviewer, as it has increased our understanding and corrected our misconception regarding multivariable analysis. We have already included smoking in the model since the last revision and therefore no new changes were made this time.
VERSION 3 -REVIEW REVIEWER
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GENERAL COMMENTS
Thanks for the response, we think the authors addressed our comments properly.
